ADAM17 p.Ser54=
c.162G>A · rs762599369 · VCV1606891
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation/SpliceAI carries the signal. | ||
| Splicing | ||
| SpliceAI | Δ0.40 | donor loss at this position · masked 0 · deltas |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP -9 | GERP -12 |
| Overall | ||
| CADD | 10.12 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Ashkenazi Jewishnot grpmax-eligible | 0.0204% | 4,914 |
| East Asiangrpmax | 0.00224% | 44,642 |
| Admixed American | 0.00169% | 59,296 |
| Remaining individualsnot grpmax-eligible | 0.00161% | 62,264 |
| South Asian | 0.00111% | 90,248 |
| European (non-Finnish) | 0.000934% | 107,049 |
Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ADAM17
- Protein
- p.Ser54=
- Coding
- c.162G>A
- MANE Select
- NM_003183
- dbSNP
- rs762599369
- Type
- single nucleotide variant
- Location
- chr2:9543221 (GRCh38)
- Gene constraint
- LOEUF 0.565 · pLI 0.10 (gnomAD)
- Structure
- AlphaFold pLDDT 72.72 · 33 PDB
Disease context
inflammatory skin and bowel disease, neonatal, 1 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Neonatal erythroderma-autoinflammation-inflammatory bowel disease syndrome (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Infancy, Neonatal
Similar variants
- ADAM17 p.Ser54Leu Uncertain significance ★★ ⚠ same residue
- ADAM17 p.Arg651Ter Pathogenic/Likely pathogenic ★★ same condition
- ADAM17 p.Ala742Thr Uncertain significance ★★ ⚠ same condition
- ADAM17 p.Ala806Pro Uncertain significance ★★ ⚠ same condition
- ADAM17 p.Ala806Ser Uncertain significance ★★ ⚠ same condition
- ADAM17 p.Arg132Lys Uncertain significance ★★ ⚠ same condition
- ADAM17 p.Arg177His Uncertain significance ★★ ⚠ same condition
- ADAM17 p.Arg738Cys Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/adam17-p-ser54 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown